ELAN Q2 2021 Earnings — Elanco Animal Health Incorporated Revenue & Financial Results | Market Cap Arena

ELANElanco Animal Health Incorporated

$12B

Q2 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.3B+118.1% YoY

Gross Profit

$599M46.8% margin

Operating Income

$120M9.4% margin

Net Income

-$210M-16.4% margin

EPS (Diluted)

$-0.43

QoQ Revenue Growth

+3.0%

Cash Flow

Operating Cash Flow

$149M

Free Cash Flow

$124M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$16.8B

Total Liabilities

$8.9B

Stockholders' Equity

$8.0B

Cash & Equivalents

$580M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.3B	$586M	+118.1%
Gross Profit	$599M	$241M	+148.1%
Operating Income	$120M	$19M	+525.0%
Net Income	-$210M	-$53M	-294.7%

Revenue Segments

Pet Health

$685M54%

Farm Animal

$567M44%

Contract Manufacturing

$27M2%

Geographic Segments

Non-US

$698M55%

UNITED STATES

$581M45%